The candidate will play a critical role in building and leading a high-performing team that accelerates AstraZeneca’s emerging Cell Therapy modalities portfolio
Job Summary
The candidate will play a critical role in building and leading a high-performing team that accelerates AstraZeneca’s emerging Cell Therapy modalities portfolio.
You will design, execute, and optimize upstream Lentiviral Vector (LVV) processes with a primary focus on suspension bioreactor platforms at clinical and commercial scales.
Our dynamic environment encourages collaboration and problem-solving as we strive to deliver life-changing medicines.
Matching Summary
The candidate will play a critical role in building and leading a high-performing team that accelerates AstraZeneca’s emerging Cell Therapy modalities portfolio.
Salary
Base: $108,473.60 - $162,710.40; Bonus/Equity: short-term incentive bonus opportunity, equity-based long-term incentive program; Benefits: qualified retirement program [401(k) plan], paid vacation and holidays, paid leaves, health benefits
Skills & Requirements
Must-have
Viral Vector Process Development
suspension bioreactor platforms
Lentiviral Vector (LVV) processes
process characterization
scale-up/tech transfer
DOE studies
suspension cell culture
Nice-to-have
Lean practices and digital tools
operational feasibility and compliance
continuous improvement
regulatory filings
Key Requirements
Ph.D. with 1+ years industry experience
M.S. with 4+ years industry experience
B.S. with 5+ years industry experience
Hands on experience developing suspension-based LVV upstream processes
familiarity with clinical/commercial scale considerations